Cannabis Stocks Weekly Recap

: ACB | Aurora Cannabis Inc. News, Ratings, and Charts

ACB – This week in the cannabis sector, we saw news out of Aurora Cannabis (ACB) and GW Pharmaceuticals (GWPH), and Aphria (APHA) continues its slide.

This has been a volatile week for the cannabis sector as COVID infections continue to hit records in the United States. The ETFMG Alternative Harvest ETF (MJ) has been going up and down all week. It was priced at $13.19 on Monday afternoon, then dropped to $12.64 on Thursday morning, and is now back up to $13 as of Friday afternoon.

Aurora Cannabis (ACB) Appoints New CCO 

Aurora Cannabis (ACB) continues to execute on their business transformation plan. The company appointed Miguel Martin, President of Aurora USA, and head of Reliva to the chief commercial officer of Aurora. Mr. Martin replaces Darren Karasiuk, who has held this position at Aurora since February 2019. 

Michael Singer, Executive Chairman and Interim CEO of Aurora, said, “This appointment allows us to take full advantage of Miguel’s depth of international CPG experience to drive Aurora’s revenues and brand strength in our global core markets.”

Investors are still waiting for the company to announce a new CEO. Singer remains interim CEO for the time being. Despite the positive news, ACB stock continued to slide, falling below $12. 

Analysts Remain Bullish on GW Pharmaceuticals (GWPH)

Despite the uncertainty surrounding a possible second wave of COVID-19, analysts covering GW Pharmaceuticals (GWPH) remain bullish. H.C. Wainwright analyst Douglas Tsao recently affirmed his Buy rating on the stock. Tsao set a price target of $161. Tsao also expects the company to post earnings per share (EPS) of $0.00 for the third quarter of 2020. That would be GWPH’s first flat quarter as the company moves closer to profitability.

As Epidiolex sales ramp up across the globe, I believe there is nothing to stop GWPH from hitting $200 per share over the next 12 months. 

Aphria (APHA) Continues to Slide

Despite being the number one cannabis pick among many analysts, Aphria (APHA) can’t find footing in this market. The stock has been trading around $4 per share over for the past month. As cannabis sales are forecasted to show weaker sales in the second quarter, I understand why investors are more bearish.

Despite the low trading range, APHA was profitable well before its peers, which makes me a lot more confident about the stock. Keep your eyes on APHA over the next few weeks, especially if volatility picks up.

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Is the Bull S#*t Rally FINALLY Over?

7 “Safe-Haven” Dividend Stocks for Turbulent Times

Top 3 Investing Strategies for 2020


ACB shares were trading at $11.91 per share on Friday afternoon, up $0.14 (+1.19%). Year-to-date, ACB has declined -54.05%, versus a -0.65% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating
GWPHGet RatingGet RatingGet Rating
APHAGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

3 Energy Stocks Set to Soar Beyond Expectations

Given the geopolitical tensions, increasing global oil demand, and supply adjustments, the energy sector is poised for robust growth. Therefore, investors might consider investing in energy stocks TechnipFMC (FTI), Weatherford International (WFRD), and ChampionX (CHX), which are poised to exceed expectations. Keep reading…

Has Carnival (CCL) Stock Turned Into a Buy After Earnings Release?

Carnival Corporation (CCL) reported record revenue in its most recent quarter but still faces a negative bottom line. The collapse of Francis Scott Key Bridge brings more uncertainty to its financials. Given these events, what stance should one take with CCL stock? Read more to find out…

3 China Stocks Positioned for Long-Term Growth

Despite facing challenges, the Chinese economy has demonstrated resilience, as evidenced by recent robust industrial output and retail sales data. Given this outlook, it might be an opportune time to own three top-notch China stocks, JD.com, Inc. (JD), China Automotive Systems (CAAS), and Youdao, Inc. (DAO). Read on…

Investor Alert: “Buy the Rumor, Sell the News!”

Everyone knows that the Fed is going to cut rates at some point this year. That is the worst kept secret on the planet helping to explain how we keep making new highs for the for the S&P 500 (SPY). Unfortunately that creates an interesting predicament for stocks after rates are cut. Plus another hurdle in the 2024 Presidential election. Steve Reitmeister is here to share his insights on the market outlook along with a preview of his top 12 stocks to outperform. Read on for more...

Read More Stories

More Aurora Cannabis Inc. (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News